ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Zhongshan Hospital, Fudan University at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Zhongshan Hospital, Fudan University takes part in 10 sessions at ESMO 2026 in Madrid. Its program focuses on treatment strategies and biomarkers in gastrointestinal cancers, including colorectal, gastric and liver cancers. Specific topics include combinations of immunotherapy and chemotherapy for advanced colorectal cancer and blood-based tumour DNA tests to assess cancer risk and recurrence.
| Organization | ESMO 2026 Attendance |
|---|---|
ZH Zhongshan Hospital, Fudan University Shanghai, China | |
Teaching hospital of Fudan University in Shanghai, China. | Poster Fri Oct 23 13:00–15:00 A hospital integrated digital oncology platform to optimise HCC MDT workflow and support recurrence risk stratification Gastrointestinal cancersNursing & supportive care Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 A single-arm, prospective phase II clinical study on the preoperative tislelizumab -cetuximab - chemotherapy followed by salvage surgery and adjuvant tislelizumab -cetuximab for resectable, locally recurrent oral and oropharyngeal squamous cell carcinoma (OSCC) Sarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 MMR status modulates the predictive value of lymphatic invasion for lymph node metastasis in gastric cancer Gastrointestinal cancersBiomarkers & precision oncology Poster Sun Oct 25 12:00–12:45 Methylformer: A hierarchical multiple-instance transformer framework for enhanced multi-cancer early detection using cell-free DNA methylation Gastrointestinal cancersBiomarkers & precision oncology Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Tumor-agnostic ctDNA methylation profiling enables preoperative risk stratification and postoperative MRD detection in hepatocellular carcinoma Gastrointestinal cancersBiomarkers & precision oncology Poster Sun Oct 25 12:00–12:45 Abstract Sun Oct 25 17:42–17:54 Poster Mon Oct 26 12:00–12:45 |
Find decision makers at Zhongshan Hospital, Fudan University
Tell us what you sell and we’ll find the people at Zhongshan Hospital, Fudan University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction